Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella

Yhu Chering Huang, Tzou Yien Lin, Yi Jane Lin, Rey In Lien, Yi Hong Chou

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Maternal chickenpox around the time of delivery can cause severe and even fatal illness in the newborn but an effectively preventive method has not yet been established. We proposed that a combination of intravenous immunoglobulin (IVIG) and acyclovir (ACV) intravenously could effectively prevent perinatal varicella. A group of 24 newborn infants whose mother had developed a varicella rash within 14 days before and after delivery were studied. Some 15 infants whose mothers' rash appeared within 7 days before and 5 days after delivery were categorised as an at-risk group and received IVIG prophylaxis (500 mg/kg) administered soon after birth or post-natal contact either alone or with intravenous acyclovir (5 mg/kg every 8 h) for a total of 5 days starting from 7 days after the onset of maternal rash. Of four infants receiving IVIG alone, two developed clinical varicella. None of ten infants receiving both IVIG and ACV contracted varicella. One infant receiving ACV alone had no varicella vesicles either. Of nine infants in the not at-risk group four had undetectable varicella-zoster virus antibody on admission and developed clinical varicella subsequently. Conclusion: The combination of intravenous immunoglobulin given soon after birth and prophylactic acyclovir intravenously administered 7 days after the onset of maternal rash can effectively prevent perinatal varicella.

Original languageEnglish
Pages (from-to)91-94
Number of pages4
JournalEuropean Journal of Pediatrics
Volume160
Issue number2
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Acyclovir
Chickenpox
Intravenous Immunoglobulins
Exanthema
Mothers
Parturition
Newborn Infant
Human Herpesvirus 3
Antibodies

Keywords

  • Acyclovir
  • Intravenous immunoglobulin
  • Perinatal varicella

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. / Huang, Yhu Chering; Lin, Tzou Yien; Lin, Yi Jane; Lien, Rey In; Chou, Yi Hong.

In: European Journal of Pediatrics, Vol. 160, No. 2, 2001, p. 91-94.

Research output: Contribution to journalArticle

Huang, Yhu Chering ; Lin, Tzou Yien ; Lin, Yi Jane ; Lien, Rey In ; Chou, Yi Hong. / Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. In: European Journal of Pediatrics. 2001 ; Vol. 160, No. 2. pp. 91-94.
@article{c65105c374a245db960560b3f8d43c28,
title = "Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella",
abstract = "Maternal chickenpox around the time of delivery can cause severe and even fatal illness in the newborn but an effectively preventive method has not yet been established. We proposed that a combination of intravenous immunoglobulin (IVIG) and acyclovir (ACV) intravenously could effectively prevent perinatal varicella. A group of 24 newborn infants whose mother had developed a varicella rash within 14 days before and after delivery were studied. Some 15 infants whose mothers' rash appeared within 7 days before and 5 days after delivery were categorised as an at-risk group and received IVIG prophylaxis (500 mg/kg) administered soon after birth or post-natal contact either alone or with intravenous acyclovir (5 mg/kg every 8 h) for a total of 5 days starting from 7 days after the onset of maternal rash. Of four infants receiving IVIG alone, two developed clinical varicella. None of ten infants receiving both IVIG and ACV contracted varicella. One infant receiving ACV alone had no varicella vesicles either. Of nine infants in the not at-risk group four had undetectable varicella-zoster virus antibody on admission and developed clinical varicella subsequently. Conclusion: The combination of intravenous immunoglobulin given soon after birth and prophylactic acyclovir intravenously administered 7 days after the onset of maternal rash can effectively prevent perinatal varicella.",
keywords = "Acyclovir, Intravenous immunoglobulin, Perinatal varicella",
author = "Huang, {Yhu Chering} and Lin, {Tzou Yien} and Lin, {Yi Jane} and Lien, {Rey In} and Chou, {Yi Hong}",
year = "2001",
doi = "10.1007/s004310000640",
language = "English",
volume = "160",
pages = "91--94",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella

AU - Huang, Yhu Chering

AU - Lin, Tzou Yien

AU - Lin, Yi Jane

AU - Lien, Rey In

AU - Chou, Yi Hong

PY - 2001

Y1 - 2001

N2 - Maternal chickenpox around the time of delivery can cause severe and even fatal illness in the newborn but an effectively preventive method has not yet been established. We proposed that a combination of intravenous immunoglobulin (IVIG) and acyclovir (ACV) intravenously could effectively prevent perinatal varicella. A group of 24 newborn infants whose mother had developed a varicella rash within 14 days before and after delivery were studied. Some 15 infants whose mothers' rash appeared within 7 days before and 5 days after delivery were categorised as an at-risk group and received IVIG prophylaxis (500 mg/kg) administered soon after birth or post-natal contact either alone or with intravenous acyclovir (5 mg/kg every 8 h) for a total of 5 days starting from 7 days after the onset of maternal rash. Of four infants receiving IVIG alone, two developed clinical varicella. None of ten infants receiving both IVIG and ACV contracted varicella. One infant receiving ACV alone had no varicella vesicles either. Of nine infants in the not at-risk group four had undetectable varicella-zoster virus antibody on admission and developed clinical varicella subsequently. Conclusion: The combination of intravenous immunoglobulin given soon after birth and prophylactic acyclovir intravenously administered 7 days after the onset of maternal rash can effectively prevent perinatal varicella.

AB - Maternal chickenpox around the time of delivery can cause severe and even fatal illness in the newborn but an effectively preventive method has not yet been established. We proposed that a combination of intravenous immunoglobulin (IVIG) and acyclovir (ACV) intravenously could effectively prevent perinatal varicella. A group of 24 newborn infants whose mother had developed a varicella rash within 14 days before and after delivery were studied. Some 15 infants whose mothers' rash appeared within 7 days before and 5 days after delivery were categorised as an at-risk group and received IVIG prophylaxis (500 mg/kg) administered soon after birth or post-natal contact either alone or with intravenous acyclovir (5 mg/kg every 8 h) for a total of 5 days starting from 7 days after the onset of maternal rash. Of four infants receiving IVIG alone, two developed clinical varicella. None of ten infants receiving both IVIG and ACV contracted varicella. One infant receiving ACV alone had no varicella vesicles either. Of nine infants in the not at-risk group four had undetectable varicella-zoster virus antibody on admission and developed clinical varicella subsequently. Conclusion: The combination of intravenous immunoglobulin given soon after birth and prophylactic acyclovir intravenously administered 7 days after the onset of maternal rash can effectively prevent perinatal varicella.

KW - Acyclovir

KW - Intravenous immunoglobulin

KW - Perinatal varicella

UR - http://www.scopus.com/inward/record.url?scp=0035106430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035106430&partnerID=8YFLogxK

U2 - 10.1007/s004310000640

DO - 10.1007/s004310000640

M3 - Article

VL - 160

SP - 91

EP - 94

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 2

ER -